- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01577901
Consumer in Stream and Container Collected Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will compare the performance of the Clearblue Advanced Pregnancy Test, when used by consumers according to the instructions for use leaflet (IFUL), and by trained coordinators. Consumer testing will include both sampling in the urine stream and the testing method for urine collected into a container.
In addition, the performance of the Clearblue Advanced Pregnancy Test will be compared to that of the currently marketed Clearblue Digital Pregnancy Test for the detection of pregnancy. In this comparison, both tests will be performed by a trained coordinator using the testing method for urine collected into a container on each volunteer's urine sample.
The study will involve the recruitment of a cross-section of the target pregnancy test users in the United Kingdom, that is, women aged 18-45 who are seeking a pregnancy test. The study will aim to recruit at least 100 volunteers, a minimum of 30 (30%) of whom will be pregnant.
Volunteers will use the Clearblue Advanced Pregnancy Test device using the urine stream method of sampling according to the product instructions. In addition volunteers will be asked to collect a urine sample from the same void and conduct a second Clearblue Advanced Pregnancy Test, using the testing method for urine collected in a container. The volunteer will then complete a study questionnaire on ease of use and leaflet comprehension. The questionnaire, urine sample and used devices will be retained by SPD for evaluation Agreement between the volunteer Pregnancy Test result and study coordinator Pregnancy Test result will be reported.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bedfordshire
-
Bedford, Bedfordshire, United Kingdom, MK44 3UP
- SPD Development company Ltd.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Requiring a pregnancy test
- Willing to provide informed consent and reveal pregnancy status
Exclusion Criteria:
- Employees of SPD. Unipath, Alere or P&G Previous participation in study Previously used Clearblue Advanced Pregnancy Test.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of pregnant volunteers as determined by volunteer test result.
Time Frame: 3 months
|
Comparison of the performance of the Clearblue Advanced Pregnancy Test in consumer hands when tested using the in-stream method of testing with the performance of the device when used by a study coordinator when testing the same urine sample using the method for urine collected into a container.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pauline A Parkinson, BSc, SPD Development Company Limited
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PROTOCOL-0425
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Determination of Pregnancy Status
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR)Active, not recruitingNeurological Determination of DeathCanada
-
Baylor College of MedicineThe University of Texas Health Science Center, Houston; Universitaire Ziekenhuizen... and other collaboratorsActive, not recruiting
-
Université de SherbrookeCompletedUncontrolled Donation After Circulatory Determination of Death
-
University of L'AquilaUniversity of Palermo; Casa Sollievo della Sofferenza IRCCSUnknownValidate QUEM Method | Quantitative Determination of MensesItaly
-
Centre Hospitalier Universitaire Saint PierreCompletedDetermination of the Occlusion Pressure in Lymphatic VesselsBelgium
-
University College Hospital GalwayCompletedDetermination of the Best Predictor for Correct Baska Mask SizeIreland
-
University of ManitobaCompletedDetermination of Clinical Effects | Presence of Inflammatory Cytokines | Patients Perception of Discomfort | Titanium Scalers | UltrasonicsCanada
-
Duke UniversityTerminatedFocus is Determination of the Role of SNO-Hb in Forearm Blood Flow RegulationUnited States
-
London Health Sciences Centre Research Institute...Recruiting
-
University of NebraskaCompletedDeath | Heart Transplant Failure | Determination of Death | Outcomes ResearchUnited States
Clinical Trials on Clearblue Advanced
-
SPD Development Company LimitedCompleted
-
SPD Development Company LimitedIllingworth Research LtdCompleted
-
SPD Development Company LimitedWCCT GlobalCompleted
-
SPD Development Company LimitedWCCT GlobalCompleted
-
SPD Development Company LimitedCompleted
-
SPD Development Company LimitedCompleted
-
Quanovate Tech Inc.Completed
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompleted
-
Marquette UniversityCompleted
-
Hospital Universitari de BellvitgeOfficial Barcelona Nurses Association (COIB)Not yet recruitingNurse's Scope of PracticeSpain